Loading cancer entity…
Loading cancer entity…
Clinical trials
175 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT04106531 | Validation of a Quality of Life Metric "Prolac-10"(Prolac-10) | terminated | — | 8 | Ohio State UniversityOTHER | 1 | Dec 5, 2025 | clinicaltrials |
| NCT03515603 | Endocrine Outcome of Surgery for Pituitary Adenoma | terminated | N/A | 36 | University of UlmOTHER | 1 | May 17, 2023 | clinicaltrials |
| NCT05338125 |
| Electrophysiology of the Human Pituitary Gland |
| terminated |
| N/A |
| 1 |
| Leiden University Medical CenterOTHER |
| 1 |
| Mar 13, 2023 |
| clinicaltrials |
| NCT03930771 | Capecitabine and Temozolomide for Treatment of Recurrent Pituitary Adenomas(TMZ-Cap) | terminated | Phase 2 | 1 | Weill Medical College of Cornell UniversityOTHER | 1 | Aug 9, 2022 | clinicaltrials |
| NCT02419664 | Ga-68-DOTATOC -PET in the Management of Pituitary Tumours | terminated | Phase 3 | 22 | Göteborg UniversityOTHER | 1 | Mar 31, 2022 | clinicaltrials |
| NCT02749227 | Pasireotide LAR Therapy of Silent Corticotroph Pituitary Tumors(PASSILCORT) | terminated | Phase 2 | 4 | Columbia UniversityOTHER | 1 | Apr 27, 2021 | clinicaltrials |
| NCT02743442 | Da Vinci Transoral Robotic-assisted Surgery of Pituitary Gland(ROBOPHYSE) | terminated | N/A | 8 | Fondation Ophtalmologique Adolphe de RothschildNETWORK | 1 | Mar 29, 2021 | clinicaltrials |
| NCT00005664 | Evaluation of Patients With Endocrine-Related Conditions | terminated | — | 1,588 | Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)NIH | 1 | Dec 16, 2019 | clinicaltrials |
| NCT02629549 | Intraoperative Imaging of Pituitary Adenomas by OTL | terminated | Phase 1 | 33 | University of PennsylvaniaOTHER | 1 | Aug 6, 2019 | clinicaltrials |
| NCT00929669 | Effect of Pasireotide Long Acting Release (LAR) on Gonadotroph Adenomas(LAR) | terminated | Phase 2 | 2 | University of PennsylvaniaOTHER | 1 | Nov 28, 2017 | clinicaltrials |
| NCT00958841 | Study of Pasireotide in Patients With Rare Tumors of Neuroendocrine Origin | terminated | Phase 2 | 118 | Novartis PharmaceuticalsINDUSTRY | 12 | Jul 26, 2016 | clinicaltrials |
| NCT00798057 | Proton Radiation Therapy for Pituitary Adenoma(PI01) | terminated | — | 16 | University of FloridaOTHER | 1 | Oct 5, 2015 | clinicaltrials |
| NCT02105337 | Tegaderm and Visual Evoked Potentials | terminated | — | 6 | Rutgers, The State University of New JerseyOTHER | 1 | Mar 11, 2015 | clinicaltrials |
| NCT01088763 | Gamma-Secretase Inhibitor RO4929097 in Treating Young Patients With Relapsed or Refractory Solid Tumors, CNS Tumors, Lymphoma, or T-Cell Leukemia | terminated | Phase 1 | 129 | National Cancer Institute (NCI)NIH | 2 | Nov 5, 2014 | clinicaltrials |
| NCT00646308 | Assessment of Cardiovascular Risk Markers in Growth Hormone Deficient Patients With Nonsecreting Pituitary Adenomas | terminated | — | 60 | Columbia UniversityOTHER | 1 | Apr 26, 2011 | clinicaltrials |
Data updated 22 days agoSource updated Dec 5, 2025source: clinicaltrials